ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 392

$336K Total Retail Price of All Prescriptions

Rank: 56 out of 392

224 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 224 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 224 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
AMLODIPINE BESYLATE 313 302 1 5
OMEPRAZOLE 305 287 2 4
METOPROLOL TARTRATE 300 288 3 8
WARFARIN SODIUM 242 235 4 12
SIMVASTATIN 237 228 5 2
LISINOPRIL 233 213 6 1
HYDROCHLOROTHIAZIDE 217 213 7 7
FUROSEMIDE 206 193 8 6
LEVOTHYROXINE SODIUM 180 160 9 3
DONEPEZIL HCL 138 138 10 29
ATORVASTATIN CALCIUM 116 116 11 10
LOSARTAN POTASSIUM 112 112 12 20
TRAZODONE HCL 111 110 13 22
DIOVAN 108 93 14 57
METFORMIN HCL 103 102 15 9
FENTANYL 99 99 S2 16 56
RANITIDINE HCL 94 82 17 31
TRAMADOL HCL 90 90 18 25
POTASSIUM CHLORIDE 89 85 19 30
ATENOLOL 87 76 20 11
LOVASTATIN 86 82 21 23
METOPROLOL SUCCINATE 81 70 22 13
LANTUS 77 77 23 41
MIRTAZAPINE 75 75 24 35
ALLOPURINOL 73 53 25 38
GLIPIZIDE 72 72 26 68
GABAPENTIN 72 67 26 18
DIGOXIN 71 59 28 69
GLYBURIDE 71 71 R 28 66
PREDNISONE 66 66 30 39
KLOR-CON M20 66 64 30 63
SERTRALINE HCL 65 60 32 19
NAMENDA 65 65 32 40
FORTICAL 65 65 32 160
RISPERIDONE 63 63 35 59
TAMSULOSIN HCL 62 62 36 37
NOVOLOG 60 60 37 75
PRAVASTATIN SODIUM 59 59 38 17
CARBIDOPA-LEVODOPA 56 56 39 83
ISOSORBIDE MONONITRATE ER 56 56 39 67
DIVALPROEX SODIUM 56 43 39 87
CRESTOR 54 43 42 27
LIDODERM 54 54 42 72
FLUTICASONE PROPIONATE 53 52 44 45
CITALOPRAM HBR 52 52 45 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.